Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Diarrhea, Angioedema, Facial edema, and Episodic vomiting and 4 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Diarrhea, Episodic vomiting, Abdominal pain |
Head and neck |
HS3ST6 encodes heparan sulfate-glucosamine 3-sulfotransferase 6 (342 aa). Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to heparan sulfate.
Angioedema, hereditary, 8 is associated with mutations in the HS3ST6 gene on chromosome 16.
HS3ST6 is classified as a druggable target (Enzyme category) with score 0.0.
Genetic testing for HS3ST6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for angioedema, hereditary, 8 has been reported in the published literature.
No clinical trials have been registered for angioedema, hereditary, 8.
132 publications have been identified in PubMed for angioedema, hereditary, 8. Kisho has analyzed 30 by research type. Research spans Clinical Trial Publication (43%), Review / Meta-Analysis (27%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 13 | 43% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
Online Mendelian Inheritance in Man
2
Facial edema, Swollen lip |
Arms and legs | 1 | Edema of the dorsum of hands |
Research summaries
8 |
27% |
Disease patterns and progression | 6 | 20% |
Patient case studies | 2 | 7% |
Testing and diagnosis research | 1 | 3% |
Betschel S (2026). [PMID: 41606636](https://pubmed.ncbi.nlm.nih.gov/41606636/). *Allergy Asthma Clin Immunol*. [Review / Meta-Analysis]
Staubach P (2025). [PMID: 40380356](https://pubmed.ncbi.nlm.nih.gov/40380356/). *Allergy Asthma Proc*. [Clinical Trial Publication]
Bocquet A (2025). [PMID: 41331604](https://pubmed.ncbi.nlm.nih.gov/41331604/). *Orphanet J Rare Dis*. [Case Report / Case Series]
Cohn DM (2025). [PMID: 39445704](https://pubmed.ncbi.nlm.nih.gov/39445704/). *N Engl J Med*. [Clinical Trial Publication]
Reshef A (2025). [PMID: 39370961](https://pubmed.ncbi.nlm.nih.gov/39370961/). *Allergy*. [Clinical Trial Publication]
Singh P (2025). [PMID: 41208217](https://pubmed.ncbi.nlm.nih.gov/41208217/). *Clin Transl Sci*. [Clinical Trial Publication]
Farkas H (2025). [PMID: 40949786](https://pubmed.ncbi.nlm.nih.gov/40949786/). *World Allergy Organ J*. [Epidemiology / Natural History]
Riedl MA (2025). [PMID: 40251904](https://pubmed.ncbi.nlm.nih.gov/40251904/). *Allergy*. [Clinical Trial Publication]
Christiansen S (2025). [PMID: 39694088](https://pubmed.ncbi.nlm.nih.gov/39694088/). *Ann Allergy Asthma Immunol*. [Clinical Trial Publication]
Recke A (2025). [PMID: 40905425](https://pubmed.ncbi.nlm.nih.gov/40905425/). *J Dtsch Dermatol Ges*. [Review / Meta-Analysis]